Vasculitis associated with all trans retinoic acid (ATRA) in a case with acute promyelocytic leukemia

被引：11
|
作者：
Paydas, S [1 ]
Yavuz, S [1 ]
Disel, U [1 ]
Sahin, B [1 ]
Canbolat, T [1 ]
Tuncer, I [1 ]
机构：
[1] Cukurova Univ, Fac Med, Dept Oncol, Adana, Turkey
来源：
LEUKEMIA & LYMPHOMA | 2003年 / 44卷 / 03期
关键词：
vasculitis; ATRA; all trans-retinoic acid; APL; acute promyelocytic leukemia; Sweet's syndrome;
D O I：
10.1080/1042819021000055101
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
All trans retinoic acid is the drug of choice in the treatment of acute promyelocytic leukemia. But this drug has some side effects, some of which may be life-threatening. Retinoic acid syndrome is the most frequent and dangerous side effect of this differentiation inducing agent. Other side effects include Sweet's syndrome, vasculitis, hypercalcemia, bone marrow necrosis and fibrosis, thromboembolic events, erythema nodosum, granulomatous proliferation and some pulmonary complications. Here, we report vasculitis in a case with APL treated with ATRA and review the literature.
引用
收藏
页码：547 / 548
页数：2
相关论文
共 50 条
  • [21] Effect of all trans retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells.
    Taraboletti, G
    Borsotti, P
    Chirivi, R
    Falanga, A
    Giavazzi, R
    Barbui, T
    Rambaldi, A
    BLOOD, 1995, 86 (10) : 670 - 670
  • [22] MORBIDITY FOLLOWING TREATMENT WITH ALL-TRANS-RETINOIC ACID (ATRA) IN CHILDREN WITH ACUTE PROMYELOCYTIC LEUKEMIA (APL)
    MAHMOUD, H
    HURWITZ, C
    ROBERTS, M
    SANTANA, V
    RIBEIRO, R
    KRANCE, R
    BLOOD, 1993, 82 (10) : A249 - A249
  • [23] HYPERCALCEMIA ASSOCIATED WITH ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    SAKAKIBARA, M
    ICHIKAWA, M
    AMANO, Y
    MATSUZAWA, S
    AGEMATSU, K
    MORI, T
    KOIKE, K
    NAKAHATA, T
    KOMIYAMA, A
    LEUKEMIA RESEARCH, 1993, 17 (05) : 441 - 443
  • [24] ALL-TRANS-RETINOIC ACID (ATRA) FOR ACUTE PROMYELOCYTIC LEUKEMIA (APL) - REPORT FROM THE MEXICAN GROUP
    RUBIOBORJA, ME
    LABARDINI, MJ
    ZARATE, P
    GOMEZALMAGUER, D
    VELAZQUEZ, F
    GONZALEZLLAVEN, J
    OVILLA, MR
    SANCHEZ, CE
    BORBOLLA, R
    BLOOD, 1993, 82 (10) : A546 - A546
  • [25] PROBLEMS EXISTING IN DIFFERENTIATION THERAPY OF ACUTE PROMYELOCYTIC LEUKEMIA (APL) WITH ALL-TRANS-RETINOIC ACID (ATRA)
    WANG, ZY
    CHEN, Z
    HUANG, W
    LI, XS
    LU, JX
    HUANG, LA
    ZHANG, FQ
    GU, LJ
    OUYANG, RR
    CHEN, SJ
    SUN, GL
    BLOOD CELLS, 1993, 19 (03): : 633 - 641
  • [26] Effect of all trans-retinoic acid (ATRA) on the adhesive and motility properties of acute promyelocytic leukemia cells
    Taraboletti, G
    Borsotti, P
    Chirivi, RGS
    Vergani, V
    Falanga, A
    Barbui, T
    Giavazzi, R
    Rambaldi, A
    INTERNATIONAL JOURNAL OF CANCER, 1997, 70 (01) : 72 - 77
  • [27] Treatment of adult acute promyelocytic leukemia (APL) with trans-retinoic acid (ATRA).
    Perez, S
    Lopez-Enriquez, A
    Fradera, J
    Acaba-Sifontes, L
    Castro-Montalvo, J
    Hallman-Navarro, D
    Martinez-Poventud, G
    Pacheco, E
    Roman-Diaz, A
    Velez-Garcia, E
    BLOOD, 2001, 98 (11) : 219B - 219B
  • [28] All-trans Retinoic Acid in the Treatment of Acute Promyelocytic Leukemia
    Asou, Norio
    INTERNAL MEDICINE, 2007, 46 (02) : 91 - 93
  • [29] Treatment of acute promyelocytic leukemia with all-trans retinoic acid
    Coriu, D
    Vasilica, M
    Gociu, M
    Colita, D
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 75 - 75
  • [30] ALL-TRANS-RETINOIC ACID IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA
    DEGOS, L
    PRESSE MEDICALE, 1990, 19 (32): : 1483 - 1484
12345